nodes	percent_of_prediction	percent_of_DWPC	metapath
Desvenlafaxine—CYP3A4—breast cancer	0.285	1	CbGaD
Desvenlafaxine—CYP3A4—Exemestane—breast cancer	0.0585	0.133	CbGbCtD
Desvenlafaxine—CYP3A4—Letrozole—breast cancer	0.0497	0.113	CbGbCtD
Desvenlafaxine—CYP3A4—Anastrozole—breast cancer	0.0443	0.101	CbGbCtD
Desvenlafaxine—CYP3A4—Toremifene—breast cancer	0.0405	0.0921	CbGbCtD
Desvenlafaxine—CYP3A4—Fulvestrant—breast cancer	0.0377	0.0856	CbGbCtD
Desvenlafaxine—CYP3A4—Thiotepa—breast cancer	0.0336	0.0763	CbGbCtD
Desvenlafaxine—CYP3A4—Ixabepilone—breast cancer	0.0307	0.0698	CbGbCtD
Desvenlafaxine—CYP3A4—Lapatinib—breast cancer	0.0296	0.0672	CbGbCtD
Desvenlafaxine—CYP3A4—Raloxifene—breast cancer	0.0224	0.0509	CbGbCtD
Desvenlafaxine—CYP3A4—Vinorelbine—breast cancer	0.0164	0.0373	CbGbCtD
Desvenlafaxine—CYP3A4—Tamoxifen—breast cancer	0.0148	0.0336	CbGbCtD
Desvenlafaxine—CYP3A4—Mitoxantrone—breast cancer	0.0144	0.0328	CbGbCtD
Desvenlafaxine—CYP3A4—Paclitaxel—breast cancer	0.0115	0.0262	CbGbCtD
Desvenlafaxine—CYP3A4—Irinotecan—breast cancer	0.0114	0.0258	CbGbCtD
Desvenlafaxine—CYP3A4—Vinblastine—breast cancer	0.0101	0.023	CbGbCtD
Desvenlafaxine—CYP3A4—Docetaxel—breast cancer	0.00833	0.0189	CbGbCtD
Desvenlafaxine—CYP3A4—Doxorubicin—breast cancer	0.00621	0.0141	CbGbCtD
Desvenlafaxine—Venlafaxine—ABCG2—breast cancer	0.00116	0.286	CrCbGaD
Desvenlafaxine—Cyclopentolate—BCHE—breast cancer	0.00116	0.285	CrCbGaD
Desvenlafaxine—Venlafaxine—CYP2D6—breast cancer	0.000679	0.167	CrCbGaD
Desvenlafaxine—Venlafaxine—CYP3A4—breast cancer	0.000582	0.143	CrCbGaD
Desvenlafaxine—Venlafaxine—ABCB1—breast cancer	0.000485	0.119	CrCbGaD
Desvenlafaxine—CYP3A4—Tamoxifen metabolism—CYP1B1—breast cancer	0.000142	0.00404	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—GATA3—breast cancer	0.000141	0.00401	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Estrogen metabolism—COMT—breast cancer	0.00014	0.00399	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—SLC5A5—breast cancer	0.000139	0.00396	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000138	0.00394	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—breast cancer	0.000138	0.00394	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—breast cancer	0.000138	0.00393	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—NQO1—breast cancer	0.000134	0.00383	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—SLC2A1—breast cancer	0.000134	0.00383	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—breast cancer	0.000133	0.0038	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Monoamine Transport—TNF—breast cancer	0.000132	0.00376	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—CPT1A—breast cancer	0.000132	0.00375	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—TGFB2—breast cancer	0.00013	0.00371	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Estrogen metabolism—GSTM1—breast cancer	0.000128	0.00365	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—ESR2—breast cancer	0.000126	0.0036	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000126	0.0036	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000126	0.0036	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—HSP90AA1—breast cancer	0.000126	0.0036	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—EGR1—breast cancer	0.000125	0.00355	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—SQSTM1—breast cancer	0.000123	0.00351	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Estrogen metabolism—CYP1A1—breast cancer	0.000121	0.00346	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—SLC5A5—breast cancer	0.00012	0.00341	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—EGR1—breast cancer	0.000118	0.00337	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—TOP2A—breast cancer	0.000117	0.00334	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Irinotecan Pathway—APC—breast cancer	0.000116	0.00331	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—NQO1—breast cancer	0.000115	0.00329	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—SLC2A1—breast cancer	0.000115	0.00329	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA2—breast cancer	0.000114	0.00326	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—TNF—breast cancer	0.000113	0.00323	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—NCOA2—breast cancer	0.000113	0.00322	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—GSTP1—breast cancer	0.000112	0.00319	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—TGFBR2—breast cancer	0.000112	0.00319	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—AR—breast cancer	0.000112	0.00318	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Xenobiotics—CYP1A1—breast cancer	0.000112	0.00318	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—EZH2—breast cancer	0.000111	0.00317	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—HMOX1—breast cancer	0.00011	0.00315	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—HSP90AA1—breast cancer	0.000109	0.00309	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tamoxifen metabolism—CYP1A1—breast cancer	0.000107	0.00306	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—EGR1—breast cancer	0.000107	0.00305	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—breast cancer	0.000106	0.00302	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—COX11—breast cancer	0.000105	0.00298	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000105	0.00298	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—HGF—breast cancer	0.000103	0.00293	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—GSTM1—breast cancer	0.000103	0.00293	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—NRG1—breast cancer	0.000101	0.00288	CbGpPWpGaD
Desvenlafaxine—Photosensitivity reaction—Epirubicin—breast cancer	9.99e-05	0.000423	CcSEcCtD
Desvenlafaxine—Weight increased—Epirubicin—breast cancer	9.96e-05	0.000422	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Docetaxel—breast cancer	9.93e-05	0.000421	CcSEcCtD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—HSP90AA1—breast cancer	9.92e-05	0.00283	CbGpPWpGaD
Desvenlafaxine—Weight decreased—Epirubicin—breast cancer	9.9e-05	0.000419	CcSEcCtD
Desvenlafaxine—Insomnia—Paclitaxel—breast cancer	9.84e-05	0.000417	CcSEcCtD
Desvenlafaxine—Epistaxis—Methotrexate—breast cancer	9.83e-05	0.000416	CcSEcCtD
Desvenlafaxine—Vertigo—Capecitabine—breast cancer	9.83e-05	0.000416	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Mitoxantrone—breast cancer	9.83e-05	0.000416	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Irinotecan—breast cancer	9.83e-05	0.000416	CcSEcCtD
Desvenlafaxine—Vomiting—Thiotepa—breast cancer	9.82e-05	0.000416	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—HES1—breast cancer	9.81e-05	0.0028	CbGpPWpGaD
Desvenlafaxine—Syncope—Capecitabine—breast cancer	9.81e-05	0.000416	CcSEcCtD
Desvenlafaxine—Convulsion—Docetaxel—breast cancer	9.79e-05	0.000415	CcSEcCtD
Desvenlafaxine—Paraesthesia—Paclitaxel—breast cancer	9.77e-05	0.000414	CcSEcCtD
Desvenlafaxine—Hypertension—Docetaxel—breast cancer	9.76e-05	0.000413	CcSEcCtD
Desvenlafaxine—Rash—Thiotepa—breast cancer	9.74e-05	0.000413	CcSEcCtD
Desvenlafaxine—Dermatitis—Thiotepa—breast cancer	9.73e-05	0.000412	CcSEcCtD
Desvenlafaxine—Headache—Thiotepa—breast cancer	9.68e-05	0.00041	CcSEcCtD
Desvenlafaxine—Somnolence—Paclitaxel—breast cancer	9.67e-05	0.00041	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Epirubicin—breast cancer	9.67e-05	0.00041	CcSEcCtD
Desvenlafaxine—Palpitations—Capecitabine—breast cancer	9.67e-05	0.000409	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—EGR1—breast cancer	9.65e-05	0.00275	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA1—breast cancer	9.65e-05	0.00275	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—GSTP1—breast cancer	9.63e-05	0.00274	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—TGFBR2—breast cancer	9.63e-05	0.00274	CbGpPWpGaD
Desvenlafaxine—Loss of consciousness—Capecitabine—breast cancer	9.62e-05	0.000407	CcSEcCtD
Desvenlafaxine—Nausea—Vinorelbine—breast cancer	9.61e-05	0.000407	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC22A18—breast cancer	9.58e-05	0.00273	CbGpPWpGaD
Desvenlafaxine—Asthenia—Mitoxantrone—breast cancer	9.57e-05	0.000405	CcSEcCtD
Desvenlafaxine—Asthenia—Irinotecan—breast cancer	9.57e-05	0.000405	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	9.56e-05	0.000405	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—HMOX1—breast cancer	9.5e-05	0.00271	CbGpPWpGaD
Desvenlafaxine—Decreased appetite—Paclitaxel—breast cancer	9.46e-05	0.000401	CcSEcCtD
Desvenlafaxine—Hypertension—Capecitabine—breast cancer	9.45e-05	0.0004	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Fluorouracil—breast cancer	9.42e-05	0.000399	CcSEcCtD
Desvenlafaxine—Dry mouth—Docetaxel—breast cancer	9.41e-05	0.000398	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Paclitaxel—breast cancer	9.4e-05	0.000398	CcSEcCtD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC2A2—breast cancer	9.39e-05	0.00268	CbGpPWpGaD
Desvenlafaxine—Fatigue—Paclitaxel—breast cancer	9.38e-05	0.000397	CcSEcCtD
Desvenlafaxine—Asthenia—Gemcitabine—breast cancer	9.33e-05	0.000395	CcSEcCtD
Desvenlafaxine—Constipation—Paclitaxel—breast cancer	9.31e-05	0.000394	CcSEcCtD
Desvenlafaxine—Anxiety—Capecitabine—breast cancer	9.28e-05	0.000393	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	9.25e-05	0.000392	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Methotrexate—breast cancer	9.24e-05	0.000391	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Doxorubicin—breast cancer	9.24e-05	0.000391	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLCO1B1—breast cancer	9.22e-05	0.00263	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC2A5—breast cancer	9.22e-05	0.00263	CbGpPWpGaD
Desvenlafaxine—Weight increased—Doxorubicin—breast cancer	9.21e-05	0.00039	CcSEcCtD
Desvenlafaxine—Epistaxis—Epirubicin—breast cancer	9.2e-05	0.00039	CcSEcCtD
Desvenlafaxine—Nausea—Thiotepa—breast cancer	9.18e-05	0.000389	CcSEcCtD
Desvenlafaxine—Urethral disorder—Methotrexate—breast cancer	9.17e-05	0.000388	CcSEcCtD
Desvenlafaxine—Weight decreased—Doxorubicin—breast cancer	9.16e-05	0.000388	CcSEcCtD
Desvenlafaxine—Diarrhoea—Mitoxantrone—breast cancer	9.13e-05	0.000387	CcSEcCtD
Desvenlafaxine—Diarrhoea—Irinotecan—breast cancer	9.13e-05	0.000387	CcSEcCtD
Desvenlafaxine—Dry mouth—Capecitabine—breast cancer	9.11e-05	0.000386	CcSEcCtD
Desvenlafaxine—Shock—Docetaxel—breast cancer	9.08e-05	0.000384	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Docetaxel—breast cancer	9.05e-05	0.000383	CcSEcCtD
Desvenlafaxine—Tachycardia—Docetaxel—breast cancer	9e-05	0.000381	CcSEcCtD
Desvenlafaxine—Skin disorder—Docetaxel—breast cancer	8.96e-05	0.000379	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Doxorubicin—breast cancer	8.95e-05	0.000379	CcSEcCtD
Desvenlafaxine—Diarrhoea—Gemcitabine—breast cancer	8.89e-05	0.000377	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Methotrexate—breast cancer	8.85e-05	0.000375	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—GSTM1—breast cancer	8.85e-05	0.00252	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—HGF—breast cancer	8.85e-05	0.00252	CbGpPWpGaD
Desvenlafaxine—Dizziness—Irinotecan—breast cancer	8.82e-05	0.000374	CcSEcCtD
Desvenlafaxine—Shock—Capecitabine—breast cancer	8.79e-05	0.000372	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Capecitabine—breast cancer	8.76e-05	0.000371	CcSEcCtD
Desvenlafaxine—Eye disorder—Methotrexate—breast cancer	8.75e-05	0.00037	CcSEcCtD
Desvenlafaxine—Diarrhoea—Fluorouracil—breast cancer	8.74e-05	0.00037	CcSEcCtD
Desvenlafaxine—Tinnitus—Methotrexate—breast cancer	8.72e-05	0.000369	CcSEcCtD
Desvenlafaxine—Tachycardia—Capecitabine—breast cancer	8.72e-05	0.000369	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Methotrexate—breast cancer	8.68e-05	0.000368	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—NRG1—breast cancer	8.68e-05	0.00248	CbGpPWpGaD
Desvenlafaxine—Skin disorder—Capecitabine—breast cancer	8.67e-05	0.000367	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Epirubicin—breast cancer	8.65e-05	0.000366	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Capecitabine—breast cancer	8.63e-05	0.000366	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Epirubicin—breast cancer	8.61e-05	0.000364	CcSEcCtD
Desvenlafaxine—Urethral disorder—Epirubicin—breast cancer	8.58e-05	0.000363	CcSEcCtD
Desvenlafaxine—Epistaxis—Doxorubicin—breast cancer	8.51e-05	0.00036	CcSEcCtD
Desvenlafaxine—Angiopathy—Methotrexate—breast cancer	8.49e-05	0.000359	CcSEcCtD
Desvenlafaxine—Vomiting—Mitoxantrone—breast cancer	8.48e-05	0.000359	CcSEcCtD
Desvenlafaxine—Vomiting—Irinotecan—breast cancer	8.48e-05	0.000359	CcSEcCtD
Desvenlafaxine—Immune system disorder—Methotrexate—breast cancer	8.45e-05	0.000358	CcSEcCtD
Desvenlafaxine—Dizziness—Fluorouracil—breast cancer	8.45e-05	0.000358	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Methotrexate—breast cancer	8.43e-05	0.000357	CcSEcCtD
Desvenlafaxine—Rash—Irinotecan—breast cancer	8.41e-05	0.000356	CcSEcCtD
Desvenlafaxine—Rash—Mitoxantrone—breast cancer	8.41e-05	0.000356	CcSEcCtD
Desvenlafaxine—Dermatitis—Mitoxantrone—breast cancer	8.41e-05	0.000356	CcSEcCtD
Desvenlafaxine—Dermatitis—Irinotecan—breast cancer	8.41e-05	0.000356	CcSEcCtD
Desvenlafaxine—Chills—Methotrexate—breast cancer	8.4e-05	0.000356	CcSEcCtD
Desvenlafaxine—Headache—Irinotecan—breast cancer	8.36e-05	0.000354	CcSEcCtD
Desvenlafaxine—Headache—Mitoxantrone—breast cancer	8.36e-05	0.000354	CcSEcCtD
Desvenlafaxine—Insomnia—Docetaxel—breast cancer	8.34e-05	0.000353	CcSEcCtD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—breast cancer	8.33e-05	0.00237	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—SIRT1—breast cancer	8.31e-05	0.00237	CbGpPWpGaD
Desvenlafaxine—Paraesthesia—Docetaxel—breast cancer	8.28e-05	0.000351	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Epirubicin—breast cancer	8.28e-05	0.000351	CcSEcCtD
Desvenlafaxine—Alopecia—Methotrexate—breast cancer	8.27e-05	0.00035	CcSEcCtD
Desvenlafaxine—Vomiting—Gemcitabine—breast cancer	8.26e-05	0.00035	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—HIF1A—breast cancer	8.22e-05	0.00234	CbGpPWpGaD
Desvenlafaxine—Somnolence—Docetaxel—breast cancer	8.2e-05	0.000347	CcSEcCtD
Desvenlafaxine—Mental disorder—Methotrexate—breast cancer	8.2e-05	0.000347	CcSEcCtD
Desvenlafaxine—Rash—Gemcitabine—breast cancer	8.2e-05	0.000347	CcSEcCtD
Desvenlafaxine—Dermatitis—Gemcitabine—breast cancer	8.19e-05	0.000347	CcSEcCtD
Desvenlafaxine—Eye disorder—Epirubicin—breast cancer	8.18e-05	0.000347	CcSEcCtD
Desvenlafaxine—Tinnitus—Epirubicin—breast cancer	8.16e-05	0.000346	CcSEcCtD
Desvenlafaxine—Malnutrition—Methotrexate—breast cancer	8.15e-05	0.000345	CcSEcCtD
Desvenlafaxine—Headache—Gemcitabine—breast cancer	8.14e-05	0.000345	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Epirubicin—breast cancer	8.13e-05	0.000344	CcSEcCtD
Desvenlafaxine—Vomiting—Fluorouracil—breast cancer	8.13e-05	0.000344	CcSEcCtD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—CHST9—breast cancer	8.09e-05	0.00231	CbGpPWpGaD
Desvenlafaxine—Insomnia—Capecitabine—breast cancer	8.08e-05	0.000342	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—TYMS—breast cancer	8.06e-05	0.0023	CbGpPWpGaD
Desvenlafaxine—Rash—Fluorouracil—breast cancer	8.06e-05	0.000341	CcSEcCtD
Desvenlafaxine—Dermatitis—Fluorouracil—breast cancer	8.05e-05	0.000341	CcSEcCtD
Desvenlafaxine—Paraesthesia—Capecitabine—breast cancer	8.02e-05	0.00034	CcSEcCtD
Desvenlafaxine—Decreased appetite—Docetaxel—breast cancer	8.02e-05	0.00034	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Paclitaxel—breast cancer	8.02e-05	0.000339	CcSEcCtD
Desvenlafaxine—Headache—Fluorouracil—breast cancer	8.01e-05	0.000339	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Doxorubicin—breast cancer	8e-05	0.000339	CcSEcCtD
Desvenlafaxine—Dysgeusia—Methotrexate—breast cancer	7.98e-05	0.000338	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—NCOR1—breast cancer	7.97e-05	0.00227	CbGpPWpGaD
Desvenlafaxine—Gastrointestinal disorder—Docetaxel—breast cancer	7.96e-05	0.000337	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Doxorubicin—breast cancer	7.96e-05	0.000337	CcSEcCtD
Desvenlafaxine—Fatigue—Docetaxel—breast cancer	7.95e-05	0.000337	CcSEcCtD
Desvenlafaxine—Angiopathy—Epirubicin—breast cancer	7.95e-05	0.000336	CcSEcCtD
Desvenlafaxine—Urethral disorder—Doxorubicin—breast cancer	7.94e-05	0.000336	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC39A6—breast cancer	7.94e-05	0.00226	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—breast cancer	7.93e-05	0.00226	CbGpPWpGaD
Desvenlafaxine—Nausea—Irinotecan—breast cancer	7.93e-05	0.000336	CcSEcCtD
Desvenlafaxine—Nausea—Mitoxantrone—breast cancer	7.93e-05	0.000336	CcSEcCtD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—breast cancer	7.92e-05	0.00226	CbGpPWpGaD
Desvenlafaxine—Immune system disorder—Epirubicin—breast cancer	7.91e-05	0.000335	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Epirubicin—breast cancer	7.89e-05	0.000334	CcSEcCtD
Desvenlafaxine—Constipation—Docetaxel—breast cancer	7.89e-05	0.000334	CcSEcCtD
Desvenlafaxine—Chills—Epirubicin—breast cancer	7.86e-05	0.000333	CcSEcCtD
Desvenlafaxine—Asthenia—Paclitaxel—breast cancer	7.81e-05	0.000331	CcSEcCtD
Desvenlafaxine—Decreased appetite—Capecitabine—breast cancer	7.76e-05	0.000329	CcSEcCtD
Desvenlafaxine—Alopecia—Epirubicin—breast cancer	7.74e-05	0.000328	CcSEcCtD
Desvenlafaxine—Nausea—Gemcitabine—breast cancer	7.72e-05	0.000327	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Capecitabine—breast cancer	7.71e-05	0.000326	CcSEcCtD
Desvenlafaxine—Fatigue—Capecitabine—breast cancer	7.7e-05	0.000326	CcSEcCtD
Desvenlafaxine—Vision blurred—Methotrexate—breast cancer	7.68e-05	0.000325	CcSEcCtD
Desvenlafaxine—Mental disorder—Epirubicin—breast cancer	7.67e-05	0.000325	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Doxorubicin—breast cancer	7.66e-05	0.000324	CcSEcCtD
Desvenlafaxine—Constipation—Capecitabine—breast cancer	7.64e-05	0.000323	CcSEcCtD
Desvenlafaxine—Malnutrition—Epirubicin—breast cancer	7.62e-05	0.000323	CcSEcCtD
Desvenlafaxine—Nausea—Fluorouracil—breast cancer	7.59e-05	0.000321	CcSEcCtD
Desvenlafaxine—Eye disorder—Doxorubicin—breast cancer	7.57e-05	0.000321	CcSEcCtD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—CYP1B1—breast cancer	7.56e-05	0.00216	CbGpPWpGaD
Desvenlafaxine—Tinnitus—Doxorubicin—breast cancer	7.55e-05	0.00032	CcSEcCtD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC5A5—breast cancer	7.53e-05	0.00215	CbGpPWpGaD
Desvenlafaxine—Cardiac disorder—Doxorubicin—breast cancer	7.52e-05	0.000318	CcSEcCtD
Desvenlafaxine—Tension—Epirubicin—breast cancer	7.48e-05	0.000317	CcSEcCtD
Desvenlafaxine—Dysgeusia—Epirubicin—breast cancer	7.47e-05	0.000316	CcSEcCtD
Desvenlafaxine—Diarrhoea—Paclitaxel—breast cancer	7.45e-05	0.000315	CcSEcCtD
Desvenlafaxine—Nervousness—Epirubicin—breast cancer	7.4e-05	0.000314	CcSEcCtD
Desvenlafaxine—Angiopathy—Doxorubicin—breast cancer	7.35e-05	0.000311	CcSEcCtD
Desvenlafaxine—Immune system disorder—Doxorubicin—breast cancer	7.32e-05	0.00031	CcSEcCtD
Desvenlafaxine—Vertigo—Methotrexate—breast cancer	7.32e-05	0.00031	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Doxorubicin—breast cancer	7.3e-05	0.000309	CcSEcCtD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC2A1—breast cancer	7.28e-05	0.00207	CbGpPWpGaD
Desvenlafaxine—Chills—Doxorubicin—breast cancer	7.27e-05	0.000308	CcSEcCtD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—breast cancer	7.27e-05	0.00207	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ATP7B—breast cancer	7.26e-05	0.00207	CbGpPWpGaD
Desvenlafaxine—Dizziness—Paclitaxel—breast cancer	7.2e-05	0.000305	CcSEcCtD
Desvenlafaxine—Vision blurred—Epirubicin—breast cancer	7.18e-05	0.000304	CcSEcCtD
Desvenlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—breast cancer	7.17e-05	0.00204	CbGpPWpGaD
Desvenlafaxine—Alopecia—Doxorubicin—breast cancer	7.16e-05	0.000303	CcSEcCtD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—CYP19A1—breast cancer	7.11e-05	0.00203	CbGpPWpGaD
Desvenlafaxine—Mental disorder—Doxorubicin—breast cancer	7.1e-05	0.000301	CcSEcCtD
Desvenlafaxine—Convulsion—Methotrexate—breast cancer	7.06e-05	0.000299	CcSEcCtD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—breast cancer	7.05e-05	0.00201	CbGpPWpGaD
Desvenlafaxine—Malnutrition—Doxorubicin—breast cancer	7.05e-05	0.000299	CcSEcCtD
Desvenlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—breast cancer	6.96e-05	0.00198	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA2—breast cancer	6.92e-05	0.00197	CbGpPWpGaD
Desvenlafaxine—Tension—Doxorubicin—breast cancer	6.92e-05	0.000293	CcSEcCtD
Desvenlafaxine—Vomiting—Paclitaxel—breast cancer	6.92e-05	0.000293	CcSEcCtD
Desvenlafaxine—Dysgeusia—Doxorubicin—breast cancer	6.91e-05	0.000292	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	6.89e-05	0.000292	CcSEcCtD
Desvenlafaxine—Rash—Paclitaxel—breast cancer	6.86e-05	0.000291	CcSEcCtD
Desvenlafaxine—Dermatitis—Paclitaxel—breast cancer	6.86e-05	0.00029	CcSEcCtD
Desvenlafaxine—Nervousness—Doxorubicin—breast cancer	6.85e-05	0.00029	CcSEcCtD
Desvenlafaxine—Vertigo—Epirubicin—breast cancer	6.85e-05	0.00029	CcSEcCtD
Desvenlafaxine—Syncope—Epirubicin—breast cancer	6.84e-05	0.000289	CcSEcCtD
Desvenlafaxine—Headache—Paclitaxel—breast cancer	6.82e-05	0.000289	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Docetaxel—breast cancer	6.8e-05	0.000288	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ABCC1—breast cancer	6.75e-05	0.00192	CbGpPWpGaD
Desvenlafaxine—Palpitations—Epirubicin—breast cancer	6.74e-05	0.000285	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Epirubicin—breast cancer	6.7e-05	0.000284	CcSEcCtD
Desvenlafaxine—Vision blurred—Doxorubicin—breast cancer	6.65e-05	0.000281	CcSEcCtD
Desvenlafaxine—Asthenia—Docetaxel—breast cancer	6.62e-05	0.00028	CcSEcCtD
Desvenlafaxine—Convulsion—Epirubicin—breast cancer	6.61e-05	0.00028	CcSEcCtD
Desvenlafaxine—Hypertension—Epirubicin—breast cancer	6.58e-05	0.000279	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Capecitabine—breast cancer	6.58e-05	0.000279	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—LEP—breast cancer	6.56e-05	0.00187	CbGpPWpGaD
Desvenlafaxine—Nervous system disorder—Methotrexate—breast cancer	6.52e-05	0.000276	CcSEcCtD
Desvenlafaxine—Anxiety—Epirubicin—breast cancer	6.47e-05	0.000274	CcSEcCtD
Desvenlafaxine—Nausea—Paclitaxel—breast cancer	6.46e-05	0.000274	CcSEcCtD
Desvenlafaxine—Skin disorder—Methotrexate—breast cancer	6.46e-05	0.000273	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	6.45e-05	0.000273	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Methotrexate—breast cancer	6.43e-05	0.000272	CcSEcCtD
Desvenlafaxine—Asthenia—Capecitabine—breast cancer	6.41e-05	0.000271	CcSEcCtD
Desvenlafaxine—Dry mouth—Epirubicin—breast cancer	6.35e-05	0.000269	CcSEcCtD
Desvenlafaxine—Vertigo—Doxorubicin—breast cancer	6.34e-05	0.000268	CcSEcCtD
Desvenlafaxine—Syncope—Doxorubicin—breast cancer	6.33e-05	0.000268	CcSEcCtD
Desvenlafaxine—Diarrhoea—Docetaxel—breast cancer	6.31e-05	0.000267	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—CDK4—breast cancer	6.28e-05	0.00179	CbGpPWpGaD
Desvenlafaxine—Palpitations—Doxorubicin—breast cancer	6.23e-05	0.000264	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Doxorubicin—breast cancer	6.2e-05	0.000263	CcSEcCtD
Desvenlafaxine—Shock—Epirubicin—breast cancer	6.12e-05	0.000259	CcSEcCtD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—breast cancer	6.12e-05	0.00174	CbGpPWpGaD
Desvenlafaxine—Convulsion—Doxorubicin—breast cancer	6.11e-05	0.000259	CcSEcCtD
Desvenlafaxine—Diarrhoea—Capecitabine—breast cancer	6.11e-05	0.000259	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—NOS2—breast cancer	6.11e-05	0.00174	CbGpPWpGaD
Desvenlafaxine—Nervous system disorder—Epirubicin—breast cancer	6.1e-05	0.000258	CcSEcCtD
Desvenlafaxine—Dizziness—Docetaxel—breast cancer	6.1e-05	0.000258	CcSEcCtD
Desvenlafaxine—Hypertension—Doxorubicin—breast cancer	6.09e-05	0.000258	CcSEcCtD
Desvenlafaxine—Tachycardia—Epirubicin—breast cancer	6.07e-05	0.000257	CcSEcCtD
Desvenlafaxine—Skin disorder—Epirubicin—breast cancer	6.04e-05	0.000256	CcSEcCtD
Desvenlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—breast cancer	6.04e-05	0.00172	CbGpPWpGaD
Desvenlafaxine—Hyperhidrosis—Epirubicin—breast cancer	6.01e-05	0.000255	CcSEcCtD
Desvenlafaxine—Insomnia—Methotrexate—breast cancer	6.01e-05	0.000255	CcSEcCtD
Desvenlafaxine—Anxiety—Doxorubicin—breast cancer	5.98e-05	0.000253	CcSEcCtD
Desvenlafaxine—Paraesthesia—Methotrexate—breast cancer	5.97e-05	0.000253	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	5.96e-05	0.000253	CcSEcCtD
Desvenlafaxine—Somnolence—Methotrexate—breast cancer	5.91e-05	0.00025	CcSEcCtD
Desvenlafaxine—Dizziness—Capecitabine—breast cancer	5.91e-05	0.00025	CcSEcCtD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—breast cancer	5.89e-05	0.00168	CbGpPWpGaD
Desvenlafaxine—Dry mouth—Doxorubicin—breast cancer	5.87e-05	0.000249	CcSEcCtD
Desvenlafaxine—Vomiting—Docetaxel—breast cancer	5.86e-05	0.000248	CcSEcCtD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—breast cancer	5.83e-05	0.00166	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—breast cancer	5.83e-05	0.00166	CbGpPWpGaD
Desvenlafaxine—Rash—Docetaxel—breast cancer	5.82e-05	0.000246	CcSEcCtD
Desvenlafaxine—Dermatitis—Docetaxel—breast cancer	5.81e-05	0.000246	CcSEcCtD
Desvenlafaxine—Decreased appetite—Methotrexate—breast cancer	5.78e-05	0.000245	CcSEcCtD
Desvenlafaxine—Headache—Docetaxel—breast cancer	5.78e-05	0.000245	CcSEcCtD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—breast cancer	5.75e-05	0.00164	CbGpPWpGaD
Desvenlafaxine—Gastrointestinal disorder—Methotrexate—breast cancer	5.74e-05	0.000243	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—TUBB3—breast cancer	5.74e-05	0.00164	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—CYP1A1—breast cancer	5.73e-05	0.00163	CbGpPWpGaD
Desvenlafaxine—Fatigue—Methotrexate—breast cancer	5.73e-05	0.000243	CcSEcCtD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—breast cancer	5.72e-05	0.00163	CbGpPWpGaD
Desvenlafaxine—Vomiting—Capecitabine—breast cancer	5.68e-05	0.00024	CcSEcCtD
Desvenlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—breast cancer	5.67e-05	0.00162	CbGpPWpGaD
Desvenlafaxine—Shock—Doxorubicin—breast cancer	5.66e-05	0.00024	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Doxorubicin—breast cancer	5.65e-05	0.000239	CcSEcCtD
Desvenlafaxine—Rash—Capecitabine—breast cancer	5.63e-05	0.000238	CcSEcCtD
Desvenlafaxine—Insomnia—Epirubicin—breast cancer	5.63e-05	0.000238	CcSEcCtD
Desvenlafaxine—Dermatitis—Capecitabine—breast cancer	5.63e-05	0.000238	CcSEcCtD
Desvenlafaxine—CYP3A4—Biological oxidations—ALDH1A1—breast cancer	5.63e-05	0.0016	CbGpPWpGaD
Desvenlafaxine—Tachycardia—Doxorubicin—breast cancer	5.62e-05	0.000238	CcSEcCtD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—NCOA2—breast cancer	5.61e-05	0.0016	CbGpPWpGaD
Desvenlafaxine—Headache—Capecitabine—breast cancer	5.59e-05	0.000237	CcSEcCtD
Desvenlafaxine—Skin disorder—Doxorubicin—breast cancer	5.59e-05	0.000237	CcSEcCtD
Desvenlafaxine—Paraesthesia—Epirubicin—breast cancer	5.59e-05	0.000237	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Doxorubicin—breast cancer	5.57e-05	0.000236	CcSEcCtD
Desvenlafaxine—Somnolence—Epirubicin—breast cancer	5.53e-05	0.000234	CcSEcCtD
Desvenlafaxine—Nausea—Docetaxel—breast cancer	5.48e-05	0.000232	CcSEcCtD
Desvenlafaxine—Decreased appetite—Epirubicin—breast cancer	5.41e-05	0.000229	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Epirubicin—breast cancer	5.37e-05	0.000227	CcSEcCtD
Desvenlafaxine—Fatigue—Epirubicin—breast cancer	5.36e-05	0.000227	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—breast cancer	5.34e-05	0.00152	CbGpPWpGaD
Desvenlafaxine—Constipation—Epirubicin—breast cancer	5.32e-05	0.000225	CcSEcCtD
Desvenlafaxine—Nausea—Capecitabine—breast cancer	5.3e-05	0.000225	CcSEcCtD
Desvenlafaxine—Insomnia—Doxorubicin—breast cancer	5.21e-05	0.00022	CcSEcCtD
Desvenlafaxine—Paraesthesia—Doxorubicin—breast cancer	5.17e-05	0.000219	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—SERPINE1—breast cancer	5.14e-05	0.00147	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL1B—breast cancer	5.12e-05	0.00146	CbGpPWpGaD
Desvenlafaxine—Somnolence—Doxorubicin—breast cancer	5.12e-05	0.000217	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CASP3—breast cancer	5.11e-05	0.00146	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTA3—breast cancer	5.01e-05	0.00143	CbGpPWpGaD
Desvenlafaxine—Decreased appetite—Doxorubicin—breast cancer	5e-05	0.000212	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Doxorubicin—breast cancer	4.97e-05	0.00021	CcSEcCtD
Desvenlafaxine—Fatigue—Doxorubicin—breast cancer	4.96e-05	0.00021	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—JUN—breast cancer	4.96e-05	0.00141	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—breast cancer	4.96e-05	0.00141	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GSTA3—breast cancer	4.94e-05	0.00141	CbGpPWpGaD
Desvenlafaxine—Constipation—Doxorubicin—breast cancer	4.92e-05	0.000208	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—breast cancer	4.92e-05	0.0014	CbGpPWpGaD
Desvenlafaxine—Hypersensitivity—Methotrexate—breast cancer	4.9e-05	0.000207	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC2A2—breast cancer	4.77e-05	0.00136	CbGpPWpGaD
Desvenlafaxine—Asthenia—Methotrexate—breast cancer	4.77e-05	0.000202	CcSEcCtD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—breast cancer	4.73e-05	0.00135	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ABCG2—breast cancer	4.68e-05	0.00133	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—breast cancer	4.66e-05	0.00133	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—breast cancer	4.64e-05	0.00132	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTA4—breast cancer	4.59e-05	0.00131	CbGpPWpGaD
Desvenlafaxine—Hypersensitivity—Epirubicin—breast cancer	4.58e-05	0.000194	CcSEcCtD
Desvenlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—breast cancer	4.57e-05	0.0013	CbGpPWpGaD
Desvenlafaxine—Diarrhoea—Methotrexate—breast cancer	4.55e-05	0.000193	CcSEcCtD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GSTA4—breast cancer	4.52e-05	0.00129	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTA2—breast cancer	4.47e-05	0.00127	CbGpPWpGaD
Desvenlafaxine—Asthenia—Epirubicin—breast cancer	4.46e-05	0.000189	CcSEcCtD
Desvenlafaxine—CYP3A4—Biological oxidations—SULT1A1—breast cancer	4.41e-05	0.00126	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GPX2—breast cancer	4.41e-05	0.00126	CbGpPWpGaD
Desvenlafaxine—Dizziness—Methotrexate—breast cancer	4.4e-05	0.000186	CcSEcCtD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GPX4—breast cancer	4.35e-05	0.00124	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—SULT1A1—breast cancer	4.35e-05	0.00124	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—breast cancer	4.33e-05	0.00123	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTA1—breast cancer	4.31e-05	0.00123	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—NAT2—breast cancer	4.26e-05	0.00121	CbGpPWpGaD
Desvenlafaxine—Diarrhoea—Epirubicin—breast cancer	4.26e-05	0.00018	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Doxorubicin—breast cancer	4.24e-05	0.00018	CcSEcCtD
Desvenlafaxine—Vomiting—Methotrexate—breast cancer	4.23e-05	0.000179	CcSEcCtD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—NAT2—breast cancer	4.2e-05	0.0012	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—TGFB1—breast cancer	4.19e-05	0.0012	CbGpPWpGaD
Desvenlafaxine—Rash—Methotrexate—breast cancer	4.19e-05	0.000177	CcSEcCtD
Desvenlafaxine—Dermatitis—Methotrexate—breast cancer	4.19e-05	0.000177	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—TFRC—breast cancer	4.17e-05	0.00119	CbGpPWpGaD
Desvenlafaxine—Headache—Methotrexate—breast cancer	4.16e-05	0.000176	CcSEcCtD
Desvenlafaxine—Asthenia—Doxorubicin—breast cancer	4.13e-05	0.000175	CcSEcCtD
Desvenlafaxine—Dizziness—Epirubicin—breast cancer	4.11e-05	0.000174	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—JUN—breast cancer	4.05e-05	0.00115	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—NCOA2—breast cancer	4.01e-05	0.00114	CbGpPWpGaD
Desvenlafaxine—Vomiting—Epirubicin—breast cancer	3.96e-05	0.000167	CcSEcCtD
Desvenlafaxine—Nausea—Methotrexate—breast cancer	3.95e-05	0.000167	CcSEcCtD
Desvenlafaxine—Diarrhoea—Doxorubicin—breast cancer	3.94e-05	0.000167	CcSEcCtD
Desvenlafaxine—Rash—Epirubicin—breast cancer	3.92e-05	0.000166	CcSEcCtD
Desvenlafaxine—Dermatitis—Epirubicin—breast cancer	3.92e-05	0.000166	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—PTEN—breast cancer	3.92e-05	0.00112	CbGpPWpGaD
Desvenlafaxine—Headache—Epirubicin—breast cancer	3.9e-05	0.000165	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—MAPK8—breast cancer	3.83e-05	0.00109	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC5A5—breast cancer	3.83e-05	0.00109	CbGpPWpGaD
Desvenlafaxine—Dizziness—Doxorubicin—breast cancer	3.81e-05	0.000161	CcSEcCtD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	3.76e-05	0.00107	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—TNF—breast cancer	3.71e-05	0.00106	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC2A1—breast cancer	3.7e-05	0.00105	CbGpPWpGaD
Desvenlafaxine—Nausea—Epirubicin—breast cancer	3.7e-05	0.000156	CcSEcCtD
Desvenlafaxine—Vomiting—Doxorubicin—breast cancer	3.66e-05	0.000155	CcSEcCtD
Desvenlafaxine—Rash—Doxorubicin—breast cancer	3.63e-05	0.000154	CcSEcCtD
Desvenlafaxine—Dermatitis—Doxorubicin—breast cancer	3.63e-05	0.000154	CcSEcCtD
Desvenlafaxine—Headache—Doxorubicin—breast cancer	3.61e-05	0.000153	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—TGFB1—breast cancer	3.61e-05	0.00103	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—ALB—breast cancer	3.59e-05	0.00102	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—MDM2—breast cancer	3.54e-05	0.00101	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—MTR—breast cancer	3.48e-05	0.00099	CbGpPWpGaD
Desvenlafaxine—Nausea—Doxorubicin—breast cancer	3.42e-05	0.000145	CcSEcCtD
Desvenlafaxine—CYP3A4—Biological oxidations—HPGDS—breast cancer	3.41e-05	0.000971	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—NCOA1—breast cancer	3.38e-05	0.000964	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTT1—breast cancer	3.31e-05	0.000942	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—PLG—breast cancer	3.3e-05	0.000939	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—CYP17A1—breast cancer	3.13e-05	0.000892	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—PTGS1—breast cancer	3.1e-05	0.000883	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—CYP17A1—breast cancer	3.09e-05	0.000879	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—HMOX1—breast cancer	3.04e-05	0.000867	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—CYP2D6—breast cancer	3.04e-05	0.000866	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL6—breast cancer	3e-05	0.000854	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—CYP2D6—breast cancer	3e-05	0.000854	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—NCOA2—breast cancer	2.98e-05	0.00085	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ABCB1—breast cancer	2.92e-05	0.000832	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—TP53—breast cancer	2.67e-05	0.000762	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—CYP1B1—breast cancer	2.63e-05	0.000751	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—CYP1B1—breast cancer	2.6e-05	0.00074	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—NCOA1—breast cancer	2.51e-05	0.000716	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—CYP19A1—breast cancer	2.48e-05	0.000706	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—IL6—breast cancer	2.45e-05	0.000697	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—CYP19A1—breast cancer	2.44e-05	0.000696	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—COMT—breast cancer	2.3e-05	0.000656	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTP1—breast cancer	2.29e-05	0.000653	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—COMT—breast cancer	2.27e-05	0.000647	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GSTP1—breast cancer	2.26e-05	0.000644	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTM1—breast cancer	2.11e-05	0.0006	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	2.08e-05	0.000592	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—CYP1A1—breast cancer	2e-05	0.000569	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	1.97e-05	0.000561	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ALB—breast cancer	1.83e-05	0.00052	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—RAF1—breast cancer	1.65e-05	0.000471	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SYNJ2—breast cancer	1.61e-05	0.000458	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NDUFS3—breast cancer	1.49e-05	0.000425	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CHST9—breast cancer	1.4e-05	0.0004	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—COX11—breast cancer	1.33e-05	0.000379	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CDA—breast cancer	1.22e-05	0.000347	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SHMT1—breast cancer	1.22e-05	0.000347	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SLC2A5—breast cancer	1.17e-05	0.000334	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SLCO1B1—breast cancer	1.17e-05	0.000334	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—APRT—breast cancer	1.13e-05	0.000322	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ANGPTL4—breast cancer	1.06e-05	0.000303	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ESRRA—breast cancer	1.06e-05	0.000303	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HADHB—breast cancer	1.01e-05	0.000287	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GPI—breast cancer	1.01e-05	0.000287	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ALDH1A1—breast cancer	9.62e-06	0.000274	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ALDH7A1—breast cancer	9.62e-06	0.000274	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NME1—breast cancer	9.22e-06	0.000263	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—FHL2—breast cancer	9.22e-06	0.000263	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PHGDH—breast cancer	9.22e-06	0.000263	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ADSL—breast cancer	9.22e-06	0.000263	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—UMPS—breast cancer	9.22e-06	0.000263	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HPSE—breast cancer	9.04e-06	0.000258	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—LDHB—breast cancer	9.04e-06	0.000258	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—BRIP1—breast cancer	9.04e-06	0.000258	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ABCC1—breast cancer	8.57e-06	0.000244	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTA3—breast cancer	8.57e-06	0.000244	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HMMR—breast cancer	8.57e-06	0.000244	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PPARGC1B—breast cancer	8.3e-06	0.000237	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CA9—breast cancer	7.84e-06	0.000223	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTA4—breast cancer	7.84e-06	0.000223	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTA2—breast cancer	7.64e-06	0.000218	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GPX2—breast cancer	7.64e-06	0.000218	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GPX4—breast cancer	7.55e-06	0.000215	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SULT1A1—breast cancer	7.55e-06	0.000215	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTA1—breast cancer	7.37e-06	0.00021	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—IDH1—breast cancer	7.37e-06	0.00021	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NAT2—breast cancer	7.29e-06	0.000208	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—MED12—breast cancer	6.39e-06	0.000182	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—DPYD—breast cancer	6.39e-06	0.000182	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ALDOA—breast cancer	6.29e-06	0.000179	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NCOA3—breast cancer	6.11e-06	0.000174	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SLC2A2—breast cancer	6.07e-06	0.000173	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ABCG2—breast cancer	5.94e-06	0.000169	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CPT1A—breast cancer	5.94e-06	0.000169	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—MTR—breast cancer	5.94e-06	0.000169	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HPGDS—breast cancer	5.83e-06	0.000166	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HBA1—breast cancer	5.79e-06	0.000165	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ACHE—breast cancer	5.65e-06	0.000161	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTT1—breast cancer	5.65e-06	0.000161	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYP17A1—breast cancer	5.35e-06	0.000152	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PTGS1—breast cancer	5.3e-06	0.000151	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ENO1—breast cancer	5.3e-06	0.000151	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYP2D6—breast cancer	5.19e-06	0.000148	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NCOA2—breast cancer	5.1e-06	0.000145	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—FASN—breast cancer	4.95e-06	0.000141	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—BCHE—breast cancer	4.92e-06	0.00014	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SLC5A5—breast cancer	4.86e-06	0.000139	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NQO1—breast cancer	4.7e-06	0.000134	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SLC2A1—breast cancer	4.7e-06	0.000134	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYP1B1—breast cancer	4.5e-06	0.000128	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HSP90AA1—breast cancer	4.42e-06	0.000126	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NCOA1—breast cancer	4.3e-06	0.000122	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—STK11—breast cancer	4.23e-06	0.000121	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYP19A1—breast cancer	4.23e-06	0.000121	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—COMT—breast cancer	3.94e-06	0.000112	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTP1—breast cancer	3.92e-06	0.000112	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HMOX1—breast cancer	3.86e-06	0.00011	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ITPR1—breast cancer	3.86e-06	0.00011	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ABCB1—breast cancer	3.71e-06	0.000106	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—TYMS—breast cancer	3.64e-06	0.000104	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTM1—breast cancer	3.6e-06	0.000103	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NCOR1—breast cancer	3.6e-06	0.000103	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PLA2G4A—breast cancer	3.6e-06	0.000103	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GPX1—breast cancer	3.45e-06	9.83e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYP1A1—breast cancer	3.41e-06	9.73e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ERCC2—breast cancer	3.39e-06	9.65e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—MTHFR—breast cancer	3.18e-06	9.07e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CAV1—breast cancer	2.94e-06	8.37e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PIK3CG—breast cancer	2.67e-06	7.62e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PIK3CD—breast cancer	2.35e-06	6.7e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ALB—breast cancer	2.32e-06	6.61e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NOS3—breast cancer	2.22e-06	6.33e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PIK3CB—breast cancer	2.05e-06	5.84e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PTGS2—breast cancer	2.03e-06	5.79e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PTEN—breast cancer	1.77e-06	5.05e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PIK3CA—breast cancer	1.25e-06	3.56e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—AKT1—breast cancer	1.02e-06	2.91e-05	CbGpPWpGaD
